Responses
Regular and Young Investigator Award Abstracts
Immunotherapy Toxicities
1259 Comparison of blinatumomab and biosimilar CD19xCD3 BiTE responses in PBMC-humanized mice used as a preclinical lymphoma mouse model
Compose a Response to This Article
Other responses
No responses have been published for this article.
